Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 111, n° 5
pages 320-331 (mai 2018)
Doi : 10.1016/j.acvd.2017.05.009
Received : 28 February 2017 ;  accepted : 17 May 2017
Clinical research

Time course of secondary mitral regurgitation in patients with heart failure receiving cardiac resynchronization therapy: Impact on long-term outcome beyond left ventricular reverse remodelling
Évolution de la regurgitation mitrale secondaire chez des patients insuffisants cardiaques après resynchronisation cardiaque : impact sur le pronostic à long-terme au-delà du remodelage inverse
 

Figure 1




Figure 1 : 

Study flow chart. CRT: cardiac resynchronization therapy; echo: echocardiography.


Figure 2




Figure 2 : 

Course of degree of secondary mitral regurgitation (MR) after cardiac resynchronization therapy (CRT). A. Changes in degree of secondary MR immediately after CRT were studied in 198 patients. B. Changes in degree of secondary MR 9 months after CRT were studied in 172 patients.


Figure 3




Figure 3 : 

Respective changes in left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV) and left ventricular end-diastolic volume (LVEDV), according to the presence (+) or absence (–) of significant secondary mitral regurgitation (MR) immediately (A, B, C) and 9 months (D, E, F) after cardiac resynchronization therapy (CRT).


Figure 4




Figure 4 : 

Kaplan Meier event-free survival according to the presence (+) or absence (–) of significant secondary mitral regurgitation MR at baseline. A. All-cause death. B. Cardiovascular death. C. Hospitalization for heart failure.


Figure 5




Figure 5 : 

Kaplan Meier event-free survival according to the presence (+) or absence (–) of significant secondary MR immediately after cardiac resynchronization therapy (CRT). A. All-cause death. B. Cardiovascular death. C. Hospitalization for heart failure.


Figure 6




Figure 6 : 

Kaplan Meier event-free survival according to the presence (+) or absence (–) of significant secondary MR 9 months after cardiac resynchronization therapy (CRT). A. All-cause death. B. Cardiovascular death. C. Hospitalization for heart failure.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline